Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation for Treating Covid-19 Disease Symptoms

Authors

  • G Siva Ram MD Rasashastra and Bhasijya Kalpana Author

DOI:

https://doi.org/10.48165/

Keywords:

Vijaya, Cannabis, COVID-19, SARS-CoV-2, Main protease

Abstract

Covid-19 is an infectious disease caused by airborne virus SARS-CoV-2 was  declared as global pandemic by WHO on 11th March 2020. Medical community is  facing challenges in developing anti-viral medicines and vaccines, as various  mutations in novel coronal virus are causing hurdles in formulating an effective  remedy. Environment is crowded with many microorganisms including pathogens  like virus, bacteria, fungi, parasites etc. Hence immunomodulation (redirecting  immunity to natural course) is the best way to tackle such pandemic situations.  Ayurveda, the Indian system of medicine is the oldest science known to mankind has  quite a few medicines and therapies to improve immune system. Vijaya (Cannabis  sativa Linn.) is the one of the Divyaushadhi (celestial plant) mentioned in Ayurveda  having Rasayana (Rejuvenative), Vyavayi (fast diffusing) and Yogavahi (synergetic)  attributes. On the basis of Ayurvedic principles we made an attempt to interpret the  immune modulating aspect of a rare Cannabis formulation Vijaya Ghrita, presumed  to be liposomal medication that has swift bio-enhancing ability. Ayurvedic properties  of the ingredients of Vijaya Ghrita found in classical texts could treat most of the  symptoms of Covid-19 disease and the contemporary scientific researches of  Cannabis phytochemicals on Covid-19 have shown significant results in reducing the  pro-inflammatory cytokine storm, also to certain range halt the entry, replication of  SARS-CoV-2.  

Downloads

Download data is not yet available.

References

Rebecca S. et al. Levels and particle size distribution of airborne SARS-CoV-2 at a healthcare facility in Kuwait. Science of The Total Environment. 2021; 782(11): 146799.

Harvey. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19: 409–424. 3) Ayush.gov.in [homepage on the Internet]. Guidelines for AYUSH practitioners for COVID-19 [cited 2021 May 15]. Available from: https://www.ayush.gov.in/ayush guidelines.html.

Sudha K Chiluveri et al. Ayurveda Arsenal for Strengthening Host Defense System against SARS-CoV-2 Infection and Need for Whole System Research: A Narrative Review. J Res Ayurvedic Sci 2020; 4(3): 94-102.

Sharma R.K Agnivesa. Charaka Samhita. Volume II, Vimana Sthana, Chapter 3. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 140-160.

Saligrama, Saligrama nighantu, Ashtavarga, First Edition, Khemraj Srikrishnadas Prakashan, Mumbai; 2011. P. 226. 7) Anonymous, The Ayurvedic Pharmacopoeia of India, Part I, Volume I, First edition, Ministry of Health & family welfare, New Delhi. p. 126.

Mishra S Bhairava, Anandakandah, Siddhiprada Hindi translation Amrutikarana visranthi, Ullasa 15, Sloka 318, First Edition, Chaukhambha orientalia, Varanasi; 2008. p. 287.

Mishra S Sarangadhara, Sarangadhara Samhita, Pradhama khanda, chapter 4, Sloka 20, Second Edition, Chaukhambha orientalia, Varanasi; 2001. p. 16.

Mishra S Bhairava, Anandakandah, Siddhiprada Hindi translation visranthi, Ullasa 15, Sloka 336, First Edition, Chaukhambha orientalia, Varanasi; 2008. p. 289.

Mishra B Bhava misra, Bhavaprakasha nighantu, Vidyotini Hindi commentary First part, Haritakyadi varga, sloka 234, Eleventh Edition, Chaukhambha Sanskrit bhavana, Varanasi; 2007. p. 141.

Shah N, Bharat Bhaishajya Ratnakar, 4th part, Vakaradi Ghrita prakaran no.6747, Reprint Edition, B Jain publishers, New Delhi; 2012. p. 641.

Shrinivasraddi G.V, Prashanth A.S. Understanding the concept of shukra dhatu. PIJAR. 2017; 1(6): 42-53. 14) Kanchan Y, Concept of shukradhatu. International Journal of Research-Granthaalayah. 2020; 8(9): 183-187. 15) Roushan et al. Shukra dhatu of ayurveda and its affiliates in modern perspective: a review. J Adv Sci Res. 2019; 10 (4): 32-39.

Joshi et al. Concept of “Stree Shukra” in Ayurvedic Classics-Views and Reviews. Int J Ayu Pharm Chem. 2014; 1(1): 1-8.

Gupta GK, Devi G. A Conceptual Study of Presence of Shukra Dhatu in Both Sexes. Research and Reviews: A Journal of Ayurvedic Science, Yoga and Naturopathy. 2018; 5(2): 21–25.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 14, Sloka 12. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 104.

Pawar K B et al. Shukra; The Essence of all Other Dhatu: A Review. International Journal of Ayurveda and Pharma Research. 2015; 3(8): 101-105.

Kalpana K, Anukul C Kar. Concept of Vyadhikshamatva in Ayurveda- a key for healthy life. Indian Journal of Applied Research. 2015; 05(05): 425-426.

Gupta G.K. A Conceptual Study of Function of Ojas w.s.r. to Vyadhikshamatva and its Clinical Significance. Research and Reviews: A Journal of Ayurvedic Science, Yoga and Naturopathy. 2018; 5(3): 24-29

Bagde A.B et al. Ojas: The vital nectar of life. Journal of Biological & Scientific Opinion. 2014; 2(2): 203-206. 23) Kunjalal K Susruta. Susruta Samhita. English translation,

Volume I, Sutra Sthana, Chapter 14, Sloka 23. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 123.

Sharma R.K Agnivesa. Charaka Samhita. Volume I, Sutra Sthana, Chapter 3, Sloka 3. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 585.

Kunjalal K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 14, Sloka 22. Third

Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 123.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume II, Nidana Sthana, Chapter 6, Sloka 9. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 81.

Mishra S Sarangadhara. Saranhadhara Samhita. Edited Chapter 5, Sloka 17. Second Edition. Varanasi: Chaukhambha orientalia; 2001. p. 18.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 400. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Lochan K Vagbhata. Astanga hridaya. English translation Volume I, Sutra Sthana, Chapter 1, Sloka 6. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 4.

Lochan K Vagbhata. Astanga hridaya. English translation Volume I, Sutra Sthana, Chapter 11, Sloka 45. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 166.

Ram et al. Conceptual review on vijaya (cannabis sativa linn.): A forgotten ambrosia. Int. J. Res. Ayurveda Pharm. 2018; 9(2): 18-27.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 45, Sloka 84. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 421.

Sharma S. Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 27, Sloka 231. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 537.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 45, Sloka 44. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 411.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 27, Sloka 218. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 533.

S. J. Williams et al. Bronchodilator effect of delta1- tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax. 1976; 31(6): 720-723.

J. P. Hartley et al. Bronchodilator effect of delta1- tetrahydrocannabinol. Br J Clin Pharmacol. 1978; 5(6): 523-525.

H Gong Jr et al. Acute and subacute bronchial effects of oral cannabinoids. Clin Pharmacol Ther. 1984; 35(1): 26- 32.

G Siva Ram: Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation For Treating Covid-19 Disease Symptoms”: 2021; 4 (12):115-124

A. J. Hampson et al. Cannabidiol and (−)Δ9- tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998; 95(14): 8268-8273.

A. J. Hampson et al. Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci. 2000; 899(1): 274-282. 41) Grassin Delyle et al. Cannabinoids inhibit cholinergic

contraction in human airways through prejunctional CB1 receptors. Br J Pharmacol. 2014; 171(11): 2767-2777. 42) John C Ashton and Robert J Hancox. The Case for Cannabinoid CB1 Receptors as a Target for Bronchodilator Therapy for β-agonist Resistant Asthma. Curr Drug Targets. 2018; 19(11): 1344-1349.

Nichols, J. M., & Kaplan, B. Immune Responses Regulated by Cannabidiol. Cannabis and cannabinoid research,. 2020; 5(1): 12-31.

Peyravian N et al. Cannabidiol as a Novel Therapeutic for Immune Modulation. Immunotargets Ther. 2020; 9: 131- 140.

Mohammed Amira et al. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Int. J. Mol. Sci. 2020; 21(17): 6244.

Costiniuk Cecilia T and Mohammad-Ali Jenabian. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? Cytokine & growth factor reviews 2020; vol. 53: 63-65.

Giuseppe Esposito et al. The potential of cannabidiol in the COVID‐19 pandemic. Br J Pharmacol. 2020; 177(21): 4967–4970.

Wang B et al. In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging (Albany NY). 2020; 12(22): 22425–22444.

Rossi F et al. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Int J Mol Sci. 2020; 21(11): 3809.

Lucaciu Ondine et al. In quest of a new therapeutic approach in COVID-19: the endocannabinoid system. Drug metabolism reviews 2021: 1-13.

Paland N, et al. The Immunopathology of COVID-19 and the Cannabis Paradigm. Front. Immunol. 2021; 12: 327. 52) Anil S M et al. Cannabis compounds exhibit anti inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages. Scientific reports 2021; 11(1): 1462.

Lindsay B. Nicholson. The immune system. Essays Biochem. 2016; 60(3): 275-301.

Mishra S Sarangadhara, Sarangadhara Samhita, Pradhama khanda, chapter 5, Sloka 11, Second Edition, Chaukhambha orientalia, Varanasi; 2001. p. 18.

Sharma R.K Agnivesa Charaka Samhita. English translation, Volume I, Sutra Sthana, Chapter 28, Sloka 28. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 579.

Vagbhata. Astanga hridaya. English translation by Kanjiv lochan, Volume I, Sutra Sthana, Chapter 11, Sloka 37-38. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 164-165.

Fabricius, M. M. & Dandachi, D. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience. Missouri medicine. 2021; 118(1): 74-80.

https://www.thehindu.com/sci-tech/health/icmr-drops plasma-therapy-from-covid-19-treatment

guidelines/article34582184.ece.

https://www.cdc.gov/coronavirus/2019-ncov/symptoms testing/symptoms.html.

Chaolin Huang et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506.

Ragab D, et al. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020; 11: 1446.

Chen W Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death. Biol Proced Online. 2021; 23(1): 4.

Asim Kichloo et al. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost. 2020; 26: 1076029620962853.

Joan loo et al. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021; 76(4): 412-420.

Lu, H. C. & Mackie, K. An Introduction to the Endogenous Cannabinoid System. Biological psychiatry. 2016; 79(7): 516-525.

Pacher, et al. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological reviews. 2006; 58(3): 389-462.

Jin Dan, et al. Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Scientific reports. 2020; 10(1): 3309.

Ofir R. Cannabis-derived terpenes and flavonoids as potential pharmaceuticals, Israel Journal of Plant Sciences. 2021; 68(1-2): 29-37.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 405. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

G Siva Ram: Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation For Treating Covid-19 Disease Symptoms”: 2021; 4 (12):115-124

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 408. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 407. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Kaiyadeva, Kaiyadeva nighantu, Aushadhi varga, Sloka 1637 [E-Nighantu on Internet], CCRAS, Government of India, Ministry of Ayush, New Delhi; 2012 [cited 2018 Jan 9]. Available from: http://niimh.nic.in/ebooks/e

Nighantu/kaiyadevanighantu/?mod=read.

Sharma S Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 403. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 411. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 406. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 413. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 409. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Sharma S. Rasatarangini. Commentary by Sri Hari dutta sastra, Chapter 24, Sloka 402. Reprint Edition. New Delhi: Printed by Motilal Banarasidas; 2009. p. 721.

Saligrama, Saligrama nighantu, Ashtavarga, First Edition, Khemraj Srikrishnadas Prakashan, Mumbai; 2011. P. 226. 80) Mishra S.N Bhairava, Anandakandah, Siddhiprada Hindi translation Amrutikarana visranthi, Ullasa 15, Sloka 338, First Edition, Chaukhambha orientalia, Varanasi; 2008. p. 289.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 13, Sloka 14. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 248.

Kunjalal K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 45, Sloka 83. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 420.

Kurita-Ochiai, et al. Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infection and immunity. 1997; 65(1): 35-41.

Furusawa, Y., Obata, Y., Fukuda, S. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504: 446-450.

Steliou, K., et al. Butyrate histone deacetylase inhibitors. BioResearch open access. 2012; 1(4): 192-198.

Berni Canani, et al. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clinical Epigenetics. 2012; 4(1): 4.

Huang, Z., et al. Role of Vitamin A in the Immune System. J Clin Med. 2018; 7(9): 258.

Villamor & Fawzi. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clinical microbiology reviews. 2005; 18(3): 446-464.

Lewis, et al. Regulatory role of vitamin E in the immune system and inflammation. IUBMB life. 2019; 71(4): 487- 494.

Lee & Han. The Role of Vitamin E in Immunity. Nutrients. 2018; 10(11): 1614.

Vagbhata. Astanga hridaya. English translation by Kanjiv lochan, Volume I, Sutra Sthana, Chapter 5, Sloka 21-23. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 56.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 1, Sloka 109- 111. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 56.

Aranow C. Vitamin D and the immune system. Journal of investigative medicine: the official publication of the American Federation for Clinical Research.2011; 59(6): 881–886.

Chun, et al. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Frontiers in physiology. 2014; 5: 151.

Mourad, et al. Composition and nutritional value of raw milk. Issues in Biological Sciences and Pharmaceutical Research. 2014; 2: 115-122.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 11, Sloka 36. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 220.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 15, Sloka 29. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 125.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 13, Sloka 13. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 247.

Duraipandi et al. Reverse engineering of Ayurvedic lipid based formulation, ghrita by combined column chromatography, normal and reverse phase HPTLC

G Siva Ram: Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation For Treating Covid-19 Disease Symptoms”: 2021; 4 (12):115-124

analysis. BMC Complementary and Alternative Medicine. 2015; 15(62).

Chaudhary A. A comparative review study of Sneha Kalpana (Paka) vis-a-vis liposome. Ayu. 2011; 32(1): 103- 108.

Kajaria D et al. Scientific basis for using medicated ghrita in ayurvedic system of medicine. Ayurpharm Int J Ayur Alli Sci. 2013; 2(8): 254-258.

Lochan K Vagbhata. Astanga hridaya. English translation Volume I, Sutra Sthana, Chapter 11, Sloka 39. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 165.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 30, Sloka 13. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 596.

Morey, J. N., et al. Current Directions in Stress and Human Immune Function. Current opinion in psychology. 2015; 5: 13–17.

Segerstrom & Miller. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological bulletin. 2004; 130(4): 601-630.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume I, Sutra Sthana, Chapter 45, Sloka 43. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 411.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 1, Sloka 107. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 56.

Bhava misra, Bhavaprakasha nighantu, Vidyotini Hindi commentary by Brahmasankara misra, First part, Ghrita varga, sloka 4, Eleventh Edition, Chaukhambha Sanskrit bhavana, Varanasi; 2007. p. 775.

Lochan K Vagbhata. Astanga hridaya. English translation, Volume II, Nidana Sthana, Chapter 12, Sloka 1. First Edition. Varanasi: Chaukhambha Sanskrit sansthan; 2017. p. 102.

Luciana, et al. Sleep and immune function. Pflugers Archiv: European journal of physiology. 2012; 463(1): 121-137.

Besedovsky, et al. The Sleep-Immune Crosstalk in Health and Disease. Physiological reviews. 2019; 99(3): 1325- 1380.

Bagde A. B. et al. Trayopasthambas: three supportive pillars of Ayurveda. Journal of Biological & Scientific Opinion. 2013; 1(3): 250-254.

Kunjalal, K Susruta. Susruta Samhita. English translation Volume II, Chikitsa Sthana, Chapter 24, Sloka 88. Third Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 575.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume I, Sutra Sthana, Chapter 20, Sloka 52. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 384.

Sharma R.K Agnivesa Charaka Samhita. English translation Volume III, Sutra Sthana, Chapter 1/4, Sloka 32. Reprint Edition. Varanasi: Chowkhamba Sanskrit series office; 2003. p. 63.

Downloads

Published

2024-03-28

How to Cite

Ram, G. S. (2024). Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation for Treating Covid-19 Disease Symptoms . International Research Journal of Ayurveda & Yoga, 4(12), 115-124. https://doi.org/10.48165/